Skip to main content
Clinical Trials/ISRCTN18388825
ISRCTN18388825
Active, not recruiting
未知

Barriers and facilitators to deprescribing antithrombotic therapy in advanced cancer patients: A qualitative interview study of patients’, companions’ and clinicians’ experiences and perspectives

Cardiff University0 sites39 target enrollmentFebruary 8, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Cancer and deprescribing antithrombotic therapy at end-of-life
Sponsor
Cardiff University
Enrollment
39
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2023
End Date
October 1, 2024
Last Updated
last year
Study Type
Other
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18 years old and over
  • 2\. Advanced cancer (whose life expectancy is less than one year, according to the healthcare professional identifying eligible participants)
  • 3\. Receiving antithrombotic medicine for one of the following diseases: atrial fibrillation/stroke prevention, mechanical heart valve, peripheral vascular disease, and deep vein thrombosis or pulmonary embolus
  • 4\. Capacity to give informed consent
  • 5\. Capacity to undertake an interview in English
  • Companions:
  • 1\. Companions are defined as person(s) who look after and/or support the patient as identified and chosen by the patient to take part alongside them, should the companion wish to do so
  • 2\. Aged 18 years old and over
  • 3\. Capacity to give informed consent
  • 4\. Capacity to undertake an interview in English

Exclusion Criteria

  • Patients and companions:
  • 1\. Cognitive impairment
  • 2\. Unable to speak or understand English
  • 3\. Considered too unwell to participate in a 30\-60 minute interview

Outcomes

Primary Outcomes

Not specified

Similar Trials